Quarterly report pursuant to Section 13 or 15(d)

Nature of Business (Detail Narrative)

v3.23.4
Nature of Business (Detail Narrative) - USD ($)
3 Months Ended
Oct. 03, 2023
Nov. 30, 2023
Nov. 30, 2022
Aug. 31, 2023
Common stock shares issued   10,311,641   8,091,650
Exercise price   $ 3.55    
Common stock shares issued   601,661    
Exercise price   $ 0.95    
Gross proceeds from sale of common stock   $ 571,578    
Net loss attributable to shareholders   1,200,000 $ 1,800,000  
Accumulated deficit   46,900,000    
Accumulated deficit   (46,942,750)   $ (45,763,427)
Securities Purchase Agreement [Member]        
Common stock shares issued 889,272      
Pre-funded warrants issued 729,058      
Common stock shares issued during period 1,618,330      
Offering price per share $ 0.97      
Sale price per share of warrants 0.9699      
Exercise price $ 0.0001      
Net proceeds from offering $ 1,250,000      
Gross proceeds from sale of common stock $ 73,000,000      
Emergency Business Account Loan Program [Member]        
Accumulated deficit   $ (4,450,000)